Lin BioScience, Inc.
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Public
- Established
- 2016-01-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.linbioscience.com
Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)The Safety and Tolerability of LBS-007 in Patients With Relapsed or Resistant Acute Leukaemias
- First Posted Date
- 2023-03-06
- Last Posted Date
- 2025-08-17
- Lead Sponsor
- Lin BioScience, Inc
- Target Recruit Count
- 90
- Registration Number
- NCT05756322
- Locations
- 🇦🇺
Q Medical Conselling, Perth, Western Australia, Australia
🇺🇸The University of Kansas Hospital, Fairway, Kansas, United States
🇺🇸Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, Maryland, United States
News
No news found